Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Nafarelin

Known as: Nafarelin [Chemical/Ingredient], Nafarelinum, Nafarelina 
A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
OBJECTIVE To evaluate the efficacy of the GnRH agonist (GnRH-a) nafarelin compared with placebo administered for 6 months after… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
OBJECTIVES To determine the effectiveness of a 3-month course of nafarelin and, furthermore, to determine the long-term efficacy… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency often have a polycystic ovary-like syndrome… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
BACKGROUND Distinguishing between ovarian and adrenal causes of androgen excess may be difficult. We have found that women with… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Reproducibility is a key issue in both clinical and research applications of bone mineral density (BMD) measurements. To examine… Expand
Is this relevant?
Highly Cited
1989
Highly Cited
1989
To investigate the basis of polycystic ovary syndrome, we examined the responses of patients to nafarelin, a specific… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The effect on bone metabolism of an agonist analog of GnRH, nafarelin, was studied in 16 premenopausal women, who received 200… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
The purposes of this study were to investigate the effect of a superactive agonistic analog of gonadotropin-releasing hormone… Expand
Is this relevant?
Highly Cited
1986
Highly Cited
1986
The release of the peptide hormone nafarelin, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)- D-alanyl-L… Expand
Is this relevant?